Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
SLC35A2 (Solute carrier family 35 member A2) encodes a multi‑pass transmembrane transporter protein localizing predominantly to Golgi‑apparatus membrane compartments, with partial isoform populations detected within endoplasmic reticulum membrane fractions. This protein is detectable within multiple tissue‑derived cell populations and exhibits broad yet non‑uniform tissue distribution patterns. Distinct from purely soluble intracellular factors, it contains multiple transmembrane segments paired with cytosolic amino‑ and carboxyl‑terminal domains and lacks independent catalytic functional modules. It acts as a membrane-resident nucleotide-sugar transporter that supplies UDP-galactose from the cytosol to the Golgi lumen to support glycosylation under physiological conditions. Insufficient SLC35A2 protein abundance could reduce Golgi luminal UDP-galactose supply and interfere with downstream glycan modification. SLC35A2 helps sustain Golgi luminal nucleotide-sugar availability required for glycan assembly across cell populations. Distinct cellular developmental stages bring varied glycosylation demands, requiring diversified membrane‑embedded transporter proteins to support multicellular tissue physiological equilibrium. Membrane-localized SLC35A2 supports Golgi glycosylation by transporting UDP-galactose into the lumen and maintaining nucleotide-sugar availability for glycan processing.
Genetic alterations occurring within SLC35A2 can impair UDP-galactose transport and alter Golgi glycosylation readouts. SLC35A2 is a principal Golgi UDP-galactose transporter, linking cytosolic nucleotide-sugar pools with luminal glycan biosynthesis. Fluctuations in SLC35A2 expression levels tend to align with cellular glycosylation‑related developmental demands, making this target well‑suited for research addressing membrane transporter biology and intracellular glycan‑modification homeostasis. Localized to Golgi‑apparatus membranes, SLC35A2 participates in heteromeric membrane‑complex formation without driving constitutive persistent downstream signalling cascades. Its multi‑domain transmembrane architecture differentiates it from many other solute carrier proteins, supporting substrate translocation‑related molecular arrangement maintenance and selective physical contacts with partner membrane subunits. Loss of sufficient SLC35A2 function may limit Golgi UDP-galactose supply and alter intracellular glycan processing, reinforcing its research value for studies focused on Golgi‑associated nucleotide‑sugar transporter components.
Fig. 1 Conceptual schematic illustrating SLC35A2 within multi-protein assemblies embedded in Golgi-apparatus membrane.1
The biological functions of transmembrane SLC35A2 protein are focused on UDP-galactose transport into the Golgi lumen and nucleotide-sugar supply for glycosylation:
Creative Biolabs offers purified SLC35A2 membrane samples produced under unified preparation workflows, including full-length SLC35A2 constructs and isolated domain variants. Truncated domain fragments cannot support complete substrate-delivery-related complex assembly behaviours, while full-length constructs suit research focused on transporter-subunit-partner interaction and Golgi-membrane anchoring functional observation. All batches receive uniform quality screening. Functional-relevant observation may only be carried out with full-length samples under simulated Golgi-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length SLC35A2 samples retain intact partner-interaction-domain conformation after standardized purification, which supports reliable detection of weak and transient subunit-partner contacts for comparative functional analysis.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable SLC35A2 expression cell research models with varied expression levels, applicable to structural observation of multi-pass membrane transporter proteins and research into membrane-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of subunit-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-SLC35A2 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for Golgi-membrane localization mapping and identification of subunit-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within Golgi-apparatus enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SLC35A2 research:
SLC35A2 might act as a multi-pass transmembrane transporter protein and participate in heteromeric Golgi-membrane complex assembly to modulate intracellular substrate-delivery arrangement and Golgi-membrane homeostasis.
SLC35A2 expression status could alter membrane-partner-complex assembly efficiency and local Golgi-membrane-coupled molecular-interaction balance, serving as a major transporter mediator of Golgi-associated biological processes.
No, SLC35A2-associated research reagents from Creative Biolabs are exclusively built for exploring membrane-transporter-dependent intracellular glycan-processing regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length SLC35A2 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on Golgi-membrane homeostasis and membrane-transporter-mediated membrane-partner perception.
Laboratory observation schemes may include subunit-partner interaction related tests to analyse molecular-binding associated behaviors under simulated Golgi-membrane environments.
